Recently, a study demonstrated that NSPs, such as CatG, NE, and, to a lesser extent, PR3 can degrade the S protein of SARS-CoV-2 as an innate defense, consequently reducing viral infection and supporting viral clearance [13]. The gene discussed is PRTN3; the disease is viral infectious disease.